Vivek Subbiah, MD, on Data from AACR on Resistance Mechanisms to KRAS Inhibitors
Published: | Updated:
CancerNetwork® spoke with Vivek Subbiah, MD, during the virtual American Association for Cancer Research Annual Meeting 2021 to discuss the most important data to come out of the meeting regarding therapy for tumors harboring KRAS mutations.
